In what the authors say is the largest current study on long-term effects, researchers at Washington University in St. Louis found that people with COVID-19 appear to be at an increased risk of death and need care. More in medical Six months after diagnosis, although there is a more severe form of the disease.
But the University of Washington study shows what many experts have been saying over the years ̵1; you don’t want this virus, Gupta said.
Between one and six months after the patient, patients with Covid-19 had a 60% higher risk of death than patients who had never been ill with Covid-19. Will require 20% more medical care in the six months after diagnosis and more medication use.
Unfortunately, remote COVID treatment options are limited, Dr. Lee Na Wen told Cooper. But the good news is that in addition to preventing infection, vaccines may also help reduce hiking symptoms.
Gupta said many experts are still learning about the virus, its treatment, and its effects on the streets.
Studies have shown that the infection is still controlled by the vaccine.
One of the threats to keeping an epidemic under control is the spread of more invasive species. But studies have shown that vaccines still work to get them under control.
Researchers reported Thursday that a pair of coronavirus strains found in California appeared to replicate better in infected people ‘noses, something that could explain its faster transmission, researchers reported Thursday.
But blood tests from people who received the Pfizer or Moderna vaccine indicate that while the strains were slightly less sensitive. But vaccines still protect people from them.
The nasal examination revealed more than twice the virus in samples taken from people infected with this strain, compared with those infected with the older virus, indicating that the B.1.427 / B.1.429 strain was well replicated. Than and there is something that explains why Will be more contagious
But it is not as transmissible as the B.1.1.7 variable first discovered in the UK, which is now the most common variant in the United States, the team reports in the journal “Cell”.
Researchers still need to closely monitor the variables.Studies show that a blood test found that the B.1.427 / B.1.429 strain was able to partially evade the immune response.
“Previous identification and verification of variables could lead to public health-focused contact tracking efforts to slow the spread, as well as enable very timely investigation of potential priorities.” up”
Pregnant people infected with Covid-19 are at a higher risk of death.
Research also shows that pregnant women infected with Covid-19 have a significantly higher risk of poor outcomes and mortality compared to pregnant women without Covid-19, according to the hit study. Printed Thursday in the journal JAMA Pediatrics.
The researchers said their findings should alert pregnant women and doctors to strictly adhere to preventive measures against Covid-19.
They found that women infected with Covid-19 were more likely to experience negative outcomes such as mortality, miscarriages and preeclampsia, a serious pregnancy complication caused by high blood pressure. The study, led by researchers at Oxford University in the UK, found that the risk of maternal death among women infected with COVID-19 was 22 times higher than those without COVID-19.
“These deaths are concentrated in institutions from less developed regions, meaning that when comprehensive ICU services are unable to provide full service, COVID-19 in pregnancy can be fatal,” the researchers said.
Women with Covid-19 who are at a higher risk of preeclampsia because pre-existing conditions such as diabetes, hypertension and heart disease are nearly four times more likely to develop preeclampsia.
They noted that fever and shortness of breath were associated with an increased risk of complications for the mother and the newborn.
The U.S. Centers for Disease Control and Prevention has long said that pregnant women are at an increased risk for serious illnesses from COVID-19 and an increased risk of adverse outcomes such as miscarriages.
Fauci wouldn’t be surprised if Johnson & Johnson’s vaccination continued.
Meanwhile, an advisory committee on the CDC’s immunization guidelines is scheduled to meet on Friday to discuss how to continue with the Johnson & Johnson vaccine after it has been suspended to investigate the link at the time. May occur with serious blood clots.
And Dr. Anthony Fosi, director of the National Institute of Allergy and Infectious Diseases, said on Thursday he would not be surprised if the board decided to continue the vaccination as Europe did.
“I don’t want to go beyond the CDC’s recommendations, but the European Medicines Agency, which asked the same question regarding the use of J&J products in Europe, decided it would allow it. Because they felt that the risk of Covid-19 outweighs this very rare adverse event, Fauci said in an interview with KCBS Radio San Francisco.
“They’re releasing the vaccine, warning people about what to look for about the risks,” he added.
Two doses of the mRNA vaccine produced by Pfizer / BioNTech and Moderna were produced using a different technology than J & J’s Covid-19 vaccine once and were not linked to rare cases of blood clots.
Fauci said the CDC and the U.S. Food and Drug Administration’s decision to temporarily stop using the vaccine should reassure the public.
“If they take a pause for such a rare event, you can be sure they take safety very seriously,” Fauci said. With security, you just need to look at a system which is highly sensitive to use in surveillance to find adverse events.
CNN’s Jen Christensen, Maggie Fox, Lauren Mascarenhas and Christina Maxouris contributed to this report.